Navigation Links
Synthetic catalyst mimics nature's 'hydrogen economy'
Date:5/18/2009

CHAMPAIGN, Ill. By creating a model of the active site found in a naturally occurring enzyme, chemists at the University of Illinois have described a catalyst that acts like nature's most pervasive hydrogen processor.

The researchers describe their work in a paper accepted for publication in the Journal of the American Chemical Society, and posted on the journal's Web site.

Scientists have long been puzzled by nature's ability to use cheap and plentiful building blocks iron, nickel and sulfur to achieve the catalytic performance seen in rare and expensive metals. In particular, two enzymes iron-iron hydrogenase and nickel-iron hydrogenase function as hydrogen processors, much like platinum.

"Nature relies on a very elaborate architecture to support its own 'hydrogen economy,' " said Thomas B. Rauchfuss, a professor of chemistry and corresponding author of the paper. "We cracked that design by generating mock-ups of the catalytic site to include the substrate hydrogen atom."

The researchers' model of the nickel-iron complex is the first to include a bridging hydride ligand, an essential component of the catalyst.

"By better understanding the mechanism in the nickel-iron hydrogenase active site, we are learning how to develop new kinds of synthetic catalysts that may be useful in other applications," said graduate student Bryan E. Barton, lead author of the paper.

"The study of hydrogenases offers plenty of potential glamour such as the hydrogen economy, green energy and bio-fuel cells but the lasting breakthroughs result from manipulable mechanistic models like ours," said graduate student and co-author Matthew Whaley. "By building a model that contains a hydride ligand, we have proven that the behavior of these natural catalysts can be understood and optimized."


'/>"/>

Contact: James E. Kloeppel
kloeppel@illinois.edu
University of Illinois at Urbana-Champaign
Source:Eurekalert

Page: 1

Related biology news :

1. Synthetic chemical offers solution for crops facing drought
2. Using combinatorial libraries to engineer genetic circuits advances synthetic biology
3. Orientation of antenna protein in photosynthetic bacteria described
4. Synthetic biology can help extend anti-malaria drug effectiveness
5. Milestone achieved toward production of malaria treatment using synthetic biology and fermentation
6. Synthetic biology key in the 21st century
7. Synthetic biology: Is ethics a showstopper?
8. Synthetic virus supports a bat origin for SARS
9. UNC scientists teach enzyme to make synthetic heparin in more varieties
10. Biosynthetics production with detours
11. Synthetic Biology: Coming Up Fast!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology: